SATURN V CAPITAL MANAGEMENT LP

PrivateCIK: 1964437
Location

AUSTIN, TX

πŸ“‹ What this filing means

SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $180.30M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

20
Positions
$180.30M
Total AUM (reported)
8.73M
Total Shares

Allocation by class

TOTAL AUM$180.30M20 positions
COM$148.23M82.2%
COM NEW$13.25M7.3%
SHS$10.23M5.7%
SPONSORED ADR$8.59M4.8%

Portfolio Concentration

Top 328.1%4–1044.0%11–2527.9%TOP 1072.1%0%100%
Top 3$50.62M28.1%
4–10$79.41M44.0%
11–25$50.27M27.9%

Top 3 weight

28.1%

Top 10 weight

72.1%

Voting Authority Distribution

Total shares with voting rights: 8.73M

Sole

Full voting authority

8.73M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole20
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings20
Rows:

CHINOOK THERAPEUTICS INC

SOLE
COM
Shares524.81K
TypeSH
Market value$20.16M
11.18%
Sole
524.81K
Shared
0.00
None
0.00

CRINETICS PHARMACEUTICALS IN

SOLE
COM
Shares938.68K
TypeSH
Market value$16.91M
9.38%
Sole
938.68K
Shared
0.00
None
0.00

COGENT BIOSCIENCES INC

SOLE
COM
Shares1.14M
TypeSH
Market value$13.54M
7.51%
Sole
1.14M
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares406.23K
TypeSH
Market value$13.25M
7.35%
Sole
406.23K
Shared
0.00
None
0.00

CYMABAY THERAPEUTICS INC

SOLE
COM
Shares1.19M
TypeSH
Market value$13.01M
7.21%
Sole
1.19M
Shared
0.00
None
0.00

KALVISTA PHARMACEUTICALS INC

SOLE
COM
Shares1.41M
TypeSH
Market value$12.71M
7.05%
Sole
1.41M
Shared
0.00
None
0.00

BIOGEN INC

SOLE
COM
Shares41.05K
TypeSH
Market value$11.69M
6.48%
Sole
41.05K
Shared
0.00
None
0.00

HORIZON THERAPEUTICS PUB L

SOLE
SHS
Shares99.50K
TypeSH
Market value$10.23M
5.68%
Sole
99.50K
Shared
0.00
None
0.00

APELLIS PHARMACEUTICALS INC

SOLE
COM
Shares107.41K
TypeSH
Market value$9.78M
5.43%
Sole
107.41K
Shared
0.00
None
0.00

MORPHIC HLDG INC

SOLE
COM
Shares152.36K
TypeSH
Market value$8.73M
4.84%
Sole
152.36K
Shared
0.00
None
0.00

ITEOS THERAPEUTICS INC

SOLE
COM
Shares636.16K
TypeSH
Market value$8.42M
4.67%
Sole
636.16K
Shared
0.00
None
0.00

BIOMARIN PHARMACEUTICAL INC

SOLE
COM
Shares92.63K
TypeSH
Market value$8.03M
4.45%
Sole
92.63K
Shared
0.00
None
0.00

ASCENDIS PHARMA A/S

SOLE
SPONSORED ADR
Shares78.44K
TypeSH
Market value$7.00M
3.88%
Sole
78.44K
Shared
0.00
None
0.00

BIOCRYST PHARMACEUTICALS INC

SOLE
COM
Shares954.86K
TypeSH
Market value$6.72M
3.73%
Sole
954.86K
Shared
0.00
None
0.00

SAREPTA THERAPEUTICS INC

SOLE
COM
Shares53.99K
TypeSH
Market value$6.18M
3.43%
Sole
53.99K
Shared
0.00
None
0.00

ASTRIA THERAPEUTICS INC

SOLE
COM
Shares637.86K
TypeSH
Market value$5.31M
2.95%
Sole
637.86K
Shared
0.00
None
0.00

SYNDAX PHARMACEUTICALS INC

SOLE
COM
Shares173.72K
TypeSH
Market value$3.64M
2.02%
Sole
173.72K
Shared
0.00
None
0.00

SAGE THERAPEUTICS INC

SOLE
COM
Shares70.56K
TypeSH
Market value$3.32M
1.84%
Sole
70.56K
Shared
0.00
None
0.00

ARGENX SE

SOLE
SPONSORED ADR
Shares4.08K
TypeSH
Market value$1.59M
0.88%
Sole
4.08K
Shared
0.00
None
0.00

SCILEX HOLDING CO

SOLE
COM
Shares10.39K
TypeSH
Market value$57.9K
0.03%
Sole
10.39K
Shared
0.00
None
0.00
SATURN V CAPITAL MANAGEMENT LP 13F Holdings β€” 20 Positions | Finecho